Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(24)00526-6/fulltext?dgcid=hubspot_update_feature_updatealerts_langlo&utm_campaign=update-langlo&utm_medium=email&_hsenc=p2ANqtz-9oF7DYx1u46Hwm9GrUYWBAYxqcdkeEIR-tgCryVIJdZKriqkvoQILsAeAWg__NnaQ31FLP7SZ819wkUo-T_usTYq8CsQ&_hsmi=360025205&utm_content=359644198&utm_source=hs_email